Powered by: Motilal Oswal
18/08/2023 11:39:17 AM | Source: Accord Fintech
Krishna Institute of Medical Sciences rises as its arm acquires 8.06% stake in M/s Kondapur Healthcare
News By Tags | #5996 #6771 #572

Krishna Institute of Medical Sciences is currently trading at Rs. 1928.95, up by 25.50 points or 1.34% from its previous closing of Rs. 1903.45 on the BSE.

The scrip opened at Rs. 1911.70 and has touched a high and low of Rs. 1938.55 and Rs. 1907.30 respectively. So far 3344 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2075.60 on 25-Jul-2023 and a 52 week low of Rs. 1172.80 on 29-Aug-2022.

Last one week high and low of the scrip stood at Rs. 1938.55 and Rs. 1846.65 respectively. The current market cap of the company is Rs. 15448.56 crore.

The promoters holding in the company stood at 38.84%, while Institutions and Non-Institutions held 48.92% and 12.24% respectively.

Krishna Institute of Medical Sciences’ material subsidiary -- KIMS Hospital Enterprises has made an investment by acquiring equity stake of 8.06% in M/s. Kondapur Healthcare. M/s Kondapur Healthcare is a green field project which is presently under construction of a hospital. M/s. Kondapur Healthcare is yet to commence its operations.

Krishna Institute of Medical Sciences offers a comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopaedics, renal sciences, organ transplantation, and mother & child care.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here